NCT06869356View on ClinicalTrials.gov

Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China

CompletedOBSERVATIONAL

Enrollment

1,291

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

January 11, 2025

Conditions

Gastric Cancer Stage

Interventions

PROCEDURE

D2 gastrectomy

Under the requirement of the guideline for laparoscopic gastrectomy for gastric cancer (2016 edition), laparoscopic radical gastrectomy is performed in patients.

Trial Locations (1)

100050

Beijing Friendship hospital, Beijing

All Listed Sponsors

lead

Beijing Friendship Hospital

OTHER

NCT06869356 - Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China | Biotech Hunter | Biotech Hunter